Rheumatoid Arthritis Treatment Study

Study Purpose

Rheumatoid Arthritis is an inflammatory conditions where the body's immune system attacks its own tissue, including joints. Treatment of RA can be managed with a class of medications called targeted synthetic disease-modifying anti- rheumatic drug (tsDMARD). Other treatments include addition of tumor necrosis factor inhibitor (TNFi)-biologic medication to existing methotrexate (MTX) in patients where methotrexate alone may not be working well enough. This study will answer the question: Which of these two medication groups is better for RA patients to be used first? The goal is to help RA patients feel better (daily function, sleep, fatigue, pain).

Who Can Participate

Age: 18 years and older